NHS England dataset restrictions#
Last modified: 19 Mar 2026
Table 1 Specific data use terms extracted from the data sharing agreements between UK LLC (University of Bristol) and NHS England
NHS England dataset |
Restrictions to use |
|---|---|
General Practice Extraction Service (GPES) Data for Pandemic Planning and Research (GDPPR) |
1. Research must be related to COVID-19. For examples of research purposes acceptable to NHS England see the COVID-19 Public Health Directions 2020. |
COVID-19 First Positives (Second Generation Surveillance System) (COVIDSGSS) |
1. Research must be related to COVID-19. For examples of research purposes acceptable to NHS England see the COVID-19 Public Health Directions 2020. |
COVID-19 UK Non-hospital Antibody Testing Results (Pillar 3) (IELISA) |
1. Research must be related to COVID-19. For examples of research purposes acceptable to NHS England see the COVID-19 Public Health Directions 2020. |
COVID-19 UK Non-hospital Antigen Testing Results (Pillar 2) (NPEX) |
1. Research must be related to COVID-19. For examples of research purposes acceptable to NHS England see the COVID-19 Public Health Directions 2020. |
COVID-19 Hospitalisation in England Surveillance System (CHESS) |
1. Research must be related to COVID-19. For examples of research purposes acceptable to NHS England see the COVID-19 Public Health Directions 2020. |
1. Research must be related to COVID-19. For examples of research purposes acceptable to NHS England see the COVID-19 Public Health Directions 2020. |
|
1. Research must be related to COVID-19. For examples of research purposes acceptable to NHS England see the COVID-19 Public Health Directions 2020. |
|
1. Research must be related to the safety and effectiveness of medicines if PCM dataset is linked with any of these LPS: ALSPAC, EPICN, FENLAND, NICOLA, NIHRBIO_COPING, SABRE and TRACKC19. For further information see the NHSBSA Medicines Data Directions 2019. If you have access to PCM linked with any other LPS, this condition does not apply. |